Wild-Type p53 Suppresses Growth of Human Prostate Cancer Cells Containing Mutant p53 Alleles

Cancer Research

Volumn 51, Issue 17, 1991, Pages 4716-4720

  Isaacs, William B ^a   Carter, Bob S ^a   Ewing, Charles M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

ALLELES; AMINO ACID SEQUENCE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMAN; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION;

EID: 0025940113     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nigro, J. M., Baker, S. J., Presinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708,1989.
2. Takahashi, T., Nau, M. M., Chiba, I., Birrer, J. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246:491-494, 1989.
3. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249:912-915, 1990.
4. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Jebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. p53 functions as a cell-cycle control gene in osteosarcomas. Mol. Cell. Biol., 10: 5772-5781, 1990.
5. Shohat, O., Greenberg, M., Reisman, D., Oren, M., and Rotter, V. Inhibition of cell growth mediated by plasmids encoding p53 anti-sense. Oncogene, 1: 277-283, 1987.
6. Mercer, W. E., Avignolo, C., and Beserga, R. Role of p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol. Cell. Biol., 4:276-281, 1984.
7. Silverberg, E. S., Boring, C. C., and Squires, T. S. Cancer Statistics 1990. CA Cancer J. Clin., 40:9-26, 1990.
8. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and lOq in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755,1990.
9. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 27:274-281, 1978.
10. Kaighn, M. E., Narayan, D. S., Ohnuki, Y., Lechner, J. F., and Jones, L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol., 77: 16-23, 1979.
11. Hoehn, W., Schroeder, F., Riemann, J., Joebsis, A., and Hermanek, P. Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC-82). Prostate, 7:95-104, 1988.
12. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Ming Chu, T., Mirand, E. A., and Murphy, G. G. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818,1983.
13. lizumi, T., Yazaki, T., Kanoh, S., Kondo, I., and Koiso, K. Establishment of a new prostatic carcinoma cell line (TSU-Prl). J. Urol., 137: 1304-1306, 1987.
14. Baker, S. J., Presinger, A. C., Jessup, J. M., Parakeva, C., Markowitz, S., Willson, J. K. V., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
15. Kogan, S. C., Doherty, M. D., and Gitschier, J. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. N. Engl. J. Med., 317:985-990, 1987.
16. Sidransky, D., Eschenbach, A. V., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., and Vogelstein, B. Identifications of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252:706-709, 1991.
17. Gleave, M. E., Hsieh, J. T., Gao, C., von Eschenbach, A. C., Chung, L. W. K. Acceleration of human prostate cancer growth by factors produced by prostate and bone fibroblasts. Cancer Res., 51: 3753-3761,1991.
18. Findlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., and Levine, A. J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 531-539, 1988.
19. Kondoleon, S., Vissing, H., Luo, X. Y., Nagenis, R. E., Kellogg, J., and Litt, M. A hypervariable RFLP on chromosome 17pl3 is defined by an arbitrary single copy probe pl44-D6 [HGM9NoD17S34]. Nucleic Acids. Res., 15: 10605, 1987.
20. Nakamura, Y., Bragg, T., Ballard, L., Leppert, M., O'Connell, P., Lathrop, G. M., Lalouel, J-M., and White, R. Isolation and mapping of a polymorphic DNA sequence pYNH37.3 on chromosome 17p [D17S28]. Nucleic Acids Res., 16: 782, 1988.